NASDAQ: MYL       Mylan NV Ord Shs
Last Price Today's Change   Day's Range   Trading Volume
21.945   +0.785 (3.71%)  21.525 - 22.045  2,876,883


Avg Volume (4 weeks):6,513,250
4 Weeks Range:19.225 - 22.40
4 Weeks Price Volatility (%):
52 Weeks Range:16.63 - 32.23
52 Weeks Price Volatility (%):
Average Price Target: 65.00
Price Target Upside/Downside: +43.055


No recent Headlines for this stock.

Business Background

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty. Its Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream or ointment form, as well as API. Its Specialty segment is focused on respiratory and allergy therapies. The EpiPen Auto-Injector, which is used in the treatment of severe allergic reactions, is an epinephrine auto-injector. Its Perforomist Inhalation Solution is a long-acting beta2-adrenergic agonist indicated for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder (COPD) patients. The Company also markets ULTIVA, which is an analgesic agent.

  Be the first to like this.


3281  2252  464  2965 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 PFE 38.58-1.58 
 VXRT 0.853+0.21 
 NIO 4.13+0.12 
 BBT 54.24+0.75 
Partners & Brokers